Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3783
This examiner grants 100% of resolved cases
Mark Golovan is an examiner working within Tech Center 3700 and Art Unit 3783. The available data for this examiner includes 2 resolved cases. Both of these cases resulted in an allowance, which establishes an allowance rate of 100.0 percent for the applications reaching a final disposition in this docket. This rate provides an initial baseline for success in this specific examination environment.
The interview lift is recorded at 0.0 percent. Given that the baseline allowance rate is already 100.0 percent, there is no statistical room for an interview to increase the probability of a grant. This metric indicates that all cases in this sample of 2 resolved cases were successful regardless of whether an interview was conducted, suggesting that the current prosecution approach is effective.
The median time to allowance is 1443 days. This pendency figure provides a baseline for the expected duration of the prosecution process from filing to grant. While the data is limited to 2 resolved cases, these metrics offer an initial look at the examiner's outcomes and the timeline for applications in Art Unit 3783, providing a starting point for applicant strategy and expectation management.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18117897 | MICROCATHETER WITH MULTISTRAND BRAID DESIGN | Non-Final OA | Boston Scientific Medical Device Limited |
| 18325913 | SYSTEMS AND METHODS FOR DETERMINING USAGE OF BALANCED SALT SOLUTION IN AN OPHTHALMIC SURGICAL SYSTEM | Non-Final OA | Johnson & Johnson Surgical Vision, Inc. |
| 18326435 | TUBING RETENTION DEVICE | Non-Final OA | CareFusion 303, Inc. |
| 18236132 | Vascular Access Instrument | Final Rejection | Becton, Dickinson and Company |
| 18700964 | Injection Device and Method of Unlocking Operation of the Injection Device | Non-Final OA | Sanofi |
| 18115316 | INSULIN INFUSION SET | Non-Final OA | Tandem Diabetes Care, Inc. |
| 18329375 | SYSTEMS AND METHODS FOR SUBSTANTIALLY CONTINUOUS INTRAVENOUS INFUSION OF THE SAME OR SUBSTANTIALLY THE SAME MEDICAL FLUID WITH FLUID SOURCE REPLACEMENTS | Final Rejection | ICU Medical, Inc. |
| 18724354 | A sub-assembly of a medicament cassette unit | Non-Final OA | SHL Medical AG |
| 18524187 | SUB-ASSEMBLY OF A MEDICAMENT DELIVERY DEVICE | Non-Final OA | SHL MEDICAL AG |
| 18259529 | CONNECTION PROTECTOR, SECUREMENT SYSTEM HAVING THE CONNECTION PROTECTOR AND USES THEREOF | Non-Final OA | CHILDREN'S NATIONAL MEDICAL CENTER |
| 18723882 | Syringe Rigid Needle Shield With RFID Tag and Folded Antenna | Non-Final OA | Becton Dickinson France |
| 18726815 | DRUG SOLUTION INJECTION DEVICE | Non-Final OA | EOFLOW CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy